Renaissance Technologies LLC 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 09:50 am Sale |
2023-12-29 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 2,170,214 4.620% |
-174,278 (-7.43%) |
Filing |
| 2023-02-13 11:28 am Sale |
2022-12-30 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 2,344,492 5.140% |
-572,699 (-19.63%) |
Filing |
| 2022-02-11 3:50 pm Sale |
2021-12-31 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 2,917,191 6.480% |
-690,100 (-19.13%) |
Filing |
| 2021-02-11 2:18 pm Purchase |
2020-12-31 | 13G | United Therapeutics Corporation UTHR |
Renaissance Technologies LLC | 3,607,291 8.120% |
62,858 (+1.77%) |
Filing |